NITROGEN MEDICAL LIQUID
País: Israel
Língua: inglês
Origem: Ministry of Health
Características técnicas
(SPC)
21-10-2018
No momento, alguns documentos para este produto não estão disponíveis, você pode enviar uma solicitação ao nosso serviço de atendimento ao cliente e iremos notificá-lo assim que conseguirmos obtê-los.
Enviar pedido.
Enviar pedido.
Ingredientes ativos:
NITROGEN
Disponível em:
OXYGEN & ARGON WORKS,OXYGEN CENTRE LTD
Código ATC:
V03AN04
Forma farmacêutica:
LIQUEFIED GAS
Composição:
NITROGEN 99.5 %
Via de administração:
TOPICAL
Tipo de prescrição:
Required
Fabricado por:
OXYGEN & ARGON WORKS, OXYGEN CENTRE LTD, ISRAEL
Grupo terapêutico:
NITROGEN
Área terapêutica:
NITROGEN
Indicações terapêuticas:
Liquefied Nitrogen for treatment of skin lesions by freezing (cryotherapy).
Data de autorização:
2017-02-28
Características técnicas
ודי לע רשואו קדבנ ונכותו תואירבה דרשמ
י"ע עבקנ הז ןולע טמרופ
עדימ ףד
NITROGEN MEDICAL LIQUID
לזונ יאופר ןקנח
NITROGEN 99.5% ןקנח יאופר
EP (
%
5
.
9
9
)
לזונ יפל
EUROPEAN PHARMACOPOEIA
_MEDICAL GAS FOR GENERAL MEDICAL USES_
:'סמ הרבחה טרפמ
– G-02.008
ה
לזונ
ריוא תדרפהו לוזינ ךילהתב רצוימ
ה
ונ
ז
ל
ה יולימ םוימ הנש ףקות גפ
לכימ יולימה ךיראת
--
ספדומ האר( גת יבג לע
יולימה
) ןויקינ תגרד
--
99.5%
םומינימ
םישומיש זג :
( ינוציח יאופר לופיטל לזונמ
CRYOTHERAPY
) הזירא : סומרת וא דדובמ לכימ
–
דלח לא תדלפמ םייושע
:הרהזא ילזונ ןקנח ידי לע לופיטב ןמוימה אפור
לש החגשהב קר שומישל
ו תא ריכמ ,תויוותהה ,שומישה ןפואו ןונימה ,לופיטה ךשמ , שומישה תורידת תוריהזה יעצמאו תוירשפאה יאוולה
תועפותו דגנה תויוותה ,םינוכיסה
.םישרדנה
WARNINGS:
SUMMARY OF EXPOSURE
:
INHALATION OF LIQUID NITROGEN GAS MAY CAUSE INJURY TO THE PHARYNX.
LIQUID NITROGEN GAS MAY
DISPLACE OXYGEN FROM THE AIR AND CAUSE ASPHYXIA WITH CNS INJURY IF THE
EXPOSURE IS SUFFICIENTLY
PROLONGED. CARDIAC ARREST, GAS EMBOLISM, NEUROPATHIES, SYNCOPE, AND A
VARIETY OF DERMAL INJURIES
MAY OCCUR FOLLOWING TOPICAL APPLICATION.
INGESTION OF LIQUID NITROGEN CAN CAUSE INJURY TO THE OROPHARYHGEAL,
ESOPHAGEAL AND GASTRIC
MUCOSA. IN SEVERE CASES PERFORATION MAY OCCUR.
LABORATORY/ MONITORING:
A NUMBER OF CHEMICALS PRODUCE ABNORMALITIES OF THE HEMATOPOIETIC
SYSTEM, LIVER, AND KIDNEYS.
MONITORING COMPLETE BLOOD COUNT, URINALYSIS, AND LIVER AND KIDNEY
FUNCTION TESTS IS SUGGESTED FOR
PATIENTS WITH SIGNIFICANT EXPOSURE.
TREATMENT OVERVIEW:
INHALATION EXPOSURE
A) Administer 100% supplemental humidified oxygen with artificial
ventilation as required. Carefully evaluate for
Leia o documento completo
